Audicin Raises $1.9M To Develop Real-Time Nervous System Technology
Apr 1, 2026 | By Kailee Rainse

Finland-based neurotechnology company Audicin, which develops real-time nervous system regulation tools, has raised $1.9 million in funding.
SUMMARY
- Finland-based neurotechnology company Audicin, which develops real-time nervous system regulation tools, has raised $1.9 million in funding.
The round includes private investment, follow-on backing from Petteri Lahtela and Virpi Tuomivaara, along with support from Business Finland through its Deep Tech Accelerator programme, bringing total funding to around $3 million.
Audicin builds solutions using brainwave entrainment, auditory engineering, and music neuroscience to improve focus, stress recovery, productivity and sleep.
Its technology delivers adaptive background audio sessions that respond to physiological signals, supporting continuous nervous system regulation throughout the day.
RECOMMENDED FOR YOU
MannyAI funding news – Fashiontech Startup MannyAI has Secured €1.5 Million in Funding
Kailee Rainse
Nov 22, 2024
Read Also - 9fin Hits Unicorn Status With €148M Series C Funding Round
A key part of Audicin’s offering is Audicin for Apps, an SDK that integrates real-time nervous system regulation protocols into digital health, performance, and consumer applications.
It operates passively, triggered by biometric data, time of day, or in-app events, and connects with wearables such as Oura, Apple Watch, Garmin, and Whoop without requiring additional hardware.
Alongside this, the company is developing a standalone offline Sleep Headband for use in restricted environments such as healthcare and defence. The device delivers pre-set recovery programmes based on low-frequency brainwave protocols linked to deep sleep.
According to co-founder and CEO Laura Avonius the company is focused on embedding nervous system support into everyday environments enabling real time regulation without requiring dedicated user attention and expanding into contexts where maintaining recovery and performance is more challenging.
Audicin is gaining early commercial traction across sectors including defence, performance, and wellness, with a growing pipeline of enterprise opportunities and rising user engagement following recent product updates.
The new funding will support the commercialisation of its core products, including the mobile application, Sleep Headband, and Audicin for Apps. It will also fund further product development and expansion into new use cases and markets.
About Audicin
Founded in 2022, Audicin is a neurotechnology company offering an app with brain-activating audio treatments designed to improve nervous system resilience. It delivers the benefits of mindfulness in minutes through curated sound experiences. Users can simply use their own headphones while the app supports focus, relaxation, mood, creativity, and sleep throughout the day.








